Literature DB >> 25811166

Anti-atherogenic properties of date vs. pomegranate polyphenols: the benefits of the combination.

Mira Rosenblat1, Nina Volkova, Hamutal Borochov-Neori, Sylvie Judeinstein, Michael Aviram.   

Abstract

Hydrolysable tannin polyphenols in pomegranate and phenolic acids in date fruit and seeds are potent antioxidants and anti-atherogenic agents, and thus, in the present study we investigated the possible benefits of combining them in vivo in atherosclerotic apolipoprotein E KO (E(0)) mice, compared with the individual fruit. In vitro studies revealed that the date seed extract contains more polyphenols than Amari or Hallawi date extracts, and possesses a most impressive free radical scavenging capacity. Similarly, pomegranate juice (PJ), punicalagin, punicalain, gallic acid, and urolithins A and B are very potent antioxidants. E(0) mice consumed 0.5 μmol gallic acid equivalents (GAE) per mouse per day of PJ, Hallawi extract, date seed extract, or a combination for 3 weeks. Consumption of the combination was the most potent treatment, as it decreased serum cholesterol and triglyceride levels, and increased serum paraoxonase 1 (PON1) activity. Consumption of the combination also significantly reduced mouse peritoneal macrophage (MPM) oxidative stress, MPM cholesterol content, and MPM LDL uptake. Finally, the lipid peroxide content in the aortas of the mice significantly decreased, and the PON lactonase activity of the aortas increased after treatment with the combination. We thus conclude that consumption of pomegranate, together with date fruit and date seeds, has the most beneficial anti-atherogenic effects on E(0) mice serum, macrophages, and aortas, probably due to their unique and varied structures.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25811166     DOI: 10.1039/c4fo00998c

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  9 in total

Review 1.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

2.  Pro-atherogenic and pro-oxidant crosstalk between adipocytes and macrophages.

Authors:  Lili Nimri; Claudia Grajeda-Iglesias; Nina Volkova; Michael Aviram
Journal:  Eur J Nutr       Date:  2018-05-26       Impact factor: 5.614

Review 3.  Pomegranate Peel as a Source of Bioactive Compounds: A Mini Review on Their Physiological Functions.

Authors:  Yaxian Mo; Jiaqi Ma; Wentao Gao; Lei Zhang; Jiangui Li; Jingming Li; Jiachen Zang
Journal:  Front Nutr       Date:  2022-06-09

Review 4.  Fruits for Prevention and Treatment of Cardiovascular Diseases.

Authors:  Cai-Ning Zhao; Xiao Meng; Ya Li; Sha Li; Qing Liu; Guo-Yi Tang; Hua-Bin Li
Journal:  Nutrients       Date:  2017-06-13       Impact factor: 5.717

Review 5.  The Search for Dietary Supplements to Elevate or Activate Circulating Paraoxonases.

Authors:  José M Lou-Bonafonte; Clara Gabás-Rivera; María A Navarro; Jesús Osada
Journal:  Int J Mol Sci       Date:  2017-02-15       Impact factor: 5.923

6.  Punicalagin Decreases Serum Glucose Levels and Increases PON1 Activity and HDL Anti-Inflammatory Values in Balb/c Mice Fed a High-Fat Diet.

Authors:  Dana Atrahimovich; Abraham O Samson; Ali Khattib; Jacob Vaya; Soliman Khatib
Journal:  Oxid Med Cell Longev       Date:  2018-07-31       Impact factor: 6.543

Review 7.  Evaluating the In Vitro Potential of Natural Extracts to Protect Lipids from Oxidative Damage.

Authors:  Rafael Félix; Patrícia Valentão; Paula B Andrade; Carina Félix; Sara C Novais; Marco F L Lemos
Journal:  Antioxidants (Basel)       Date:  2020-03-11

Review 8.  Possible Beneficial Effects of Fresh Pomegranate Juice in SARS-CoV-2 Infection Conditions.

Authors:  Saleem Ali Banihani
Journal:  J Nutr Metab       Date:  2022-03-05

Review 9.  Ellagic Acid-Derived Urolithins as Modulators of Oxidative Stress.

Authors:  Jasmina Djedjibegovic; Aleksandra Marjanovic; Emiliano Panieri; Luciano Saso
Journal:  Oxid Med Cell Longev       Date:  2020-07-28       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.